U-101017 is a partial agonist at benzodiazepine and GABAA receptors, exhibiting anxiolytic effects; it demonstrates neuroprotective activity by significantly preserving CA1 hippocampal neurons when administered prior to ischemia; it potentiates GABA-stimulated chloride currents at low concentrations (<1 μM); it reduces stress-induced elevations in cerebral cGMP levels in a GABAA receptor-dependent manner.